Not only has the Food and Drug Administration (FDA) fielded thousands of complaints tied to less expensive, compounded versions, but a 2026 Yale secret-shopper study found many online sellers of affordable GLP-1 drugs skip basic safety steps before prescribing
Child-Pugh C patients (score 10 to 15) should generally not receive ipamorelin outside a monitored research setting, because unpredictable GH surges in severe cirrhosis could worsen insulin resistance and fluid retention
Yakar S, Courtland HW, Clemmons D
Semaglutide, the active ingredient in GLP-1 drugs, is protected in the U.S
Some concerns were expressed by the deciding FDA panel regarding the safety of this drug in the long term, including its potential role in gallbladder disease, pancreatitis, increasing heart rate as well as concerns regarding thyroid and breast cancer
The cells reduce surface receptor expression in response to chronic overstimulation